Skip to main content
SpringerLink
Log in

Chemoprevention

  • Chapter
Cancer Precursors

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976; 36:2699–702.

    PubMed  CAS  Google Scholar 

  2. Wattenberg LW. Inhibition of chemical carcinogenesis. J Natl Cancer Inst 1975; 60:11–18.

    Google Scholar 

  3. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985; 45:1–8.

    PubMed  CAS  Google Scholar 

  4. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315:1501–5.

    PubMed  CAS  Google Scholar 

  5. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323:795–801.

    PubMed  CAS  Google Scholar 

  6. Frykberg ER, Bland KI. In situ breast carcinoma. Adv Surg 1993; 26:29–72.

    PubMed  CAS  Google Scholar 

  7. Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985; 55:2698–708.

    PubMed  CAS  Google Scholar 

  8. Bruzzi P, Bonelli L, Costantini M, et al. A multicenter study of colorectal adenomas—rationale, objectives, methods and characteristics of the study cohort. Tumori 1995; 81:157–63.

    Google Scholar 

  9. Day DW, Morson BC. The adenoma-carcinoma sequence. In: Bennington JL (ed.) The pathogenesis of colorectal cancer. Philadelphia: WB Saunders Co., 1978, pp. 58–71.

    Google Scholar 

  10. Bostwick DG. Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem 1992; 16(Suppl H):10–19.

    Google Scholar 

  11. Kelloff GJ, Boone CW, Steele VE, et al. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res 1994; 54(Suppl):2015–24.

    Google Scholar 

  12. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994; 12:851–83.

    PubMed  CAS  Google Scholar 

  13. Kelloff GJ, Johnson JR, Crowell JA, et al. Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol Biomarkers Prev 1995; 4:1–10.

    PubMed  CAS  Google Scholar 

  14. Kelloff GJ, Hawk ET, Crowell JA, et al. Strategies for identification and clinical evaluation of promising chemopreventive agents. Oncology (Huntington) 1996; 10:1471–80, 1484.

    CAS  Google Scholar 

  15. Kelloff GJ, Hawk ET, Karp JE, et al. Progress in clinical chemoprevention. Semin Oncol 1997; 24:1–13.

    Google Scholar 

  16. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278:1073–7.

    Article  PubMed  CAS  Google Scholar 

  17. Lippman SM, Lee JJ, Sabichi AL. Cancer chemoprevention: progress and promise. J Natl Cancer Inst 1998; 90:1514–28.

    Article  PubMed  CAS  Google Scholar 

  18. Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis 2000; 21:525–30.

    Article  PubMed  CAS  Google Scholar 

  19. Kelloff GJ. Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res 2000; 278:199–334.

    Google Scholar 

  20. Kelloff GJ, Sigman CC, Johnson KM, et al. Perspectives on surrogate endpoints in the development of drugs that reduce the risk of cancer. Cancer Epidemiol Biomarkers Prev 2000; 9:127–34.

    PubMed  CAS  Google Scholar 

  21. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90;1371–88.

    Article  PubMed  CAS  Google Scholar 

  22. Slaughter DP, Southwick HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953; 6:963–8

    PubMed  CAS  Google Scholar 

  23. Benner SE, Hong WK, Lippman SM, et al. Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials. J Cell Biochem 1992; 16G:33–8.

    CAS  Google Scholar 

  24. Kelloff GJ, Sigman CC, Hawk ET, et al. Surrogate end-point biomarkers in chemopreventive drug development. In: Miller AB, Bartsch H, Boffetta P, et al. (eds) Biomarkers in cancer prevention, IARC Scientific Publications No. 154. Lyon: International Agency for Research on Cancer, 2001, pp. 13–26.

    Google Scholar 

  25. Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 1988; 48:235–45.

    PubMed  CAS  Google Scholar 

  26. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342:1946–52.

    Article  PubMed  CAS  Google Scholar 

  27. Hamilton SR. Pathology and biology of colorectal neoplasia. In: Young GP, Levin B, Rozen P (eds) Prevention and early detection of colorectal cancer: principles and practice, London: WB Saunders, 1996, pp. 3–21.

    Google Scholar 

  28. Roth JA, Putnam JB Jr, Rich TA, et al. Cancers of the gastrointestinal tract: cancer of the esophagus. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles & practice of oncology, 5th ed. Philadelphia: Lippincott-Raven Publishers, 1997, pp. 970–1251.

    Google Scholar 

  29. Linehan WM, Cordon-Cardo C, Isaacs W. Cancers of the genitourinary tract. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles & practice of oncology, 5th ed. Philadelphia: Lippincott-Raven Publishers, 1997, pp. 1253–395.

    Google Scholar 

  30. Kelloff GJ, Boone CW, Crowell JA, et al. Surrogate endpoint biomarkers for Phase II cancer chemoprevention trials. J Cell Biochem 1994; 19(Suppl):1–9.

    CAS  Google Scholar 

  31. Boone CW, Kelloff GJ, Steele VE. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Res 1992; 52:1651–9.

    PubMed  CAS  Google Scholar 

  32. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56:2488–92.

    PubMed  CAS  Google Scholar 

  33. Lotan R, Xu X-C, Lippman SM, et al. Suppression of retinoic acid receptor-b in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995; 332:1405–10.

    Article  PubMed  CAS  Google Scholar 

  34. Meyskens FL Jr, Surwit E, Moon TE, et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderated dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 1994; 86:539–43.

    PubMed  Google Scholar 

  35. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328:1313–16.

    Article  PubMed  CAS  Google Scholar 

  36. Bedi A, Pasricha PJ, Akhtar AJ, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55:1811–16.

    PubMed  CAS  Google Scholar 

  37. Stoner GD, Budd GT, Ganapathi R, et al. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. Adv Exp Med Biol 1999; 470:45–53.

    PubMed  CAS  Google Scholar 

  38. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759–67.

    Article  PubMed  CAS  Google Scholar 

  39. Sidransky D, Mikkelsen T, Schwechheimer K, et al. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 1992; 355:846–7.

    Article  PubMed  CAS  Google Scholar 

  40. Sidransky D, Messing E. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am 1992; 19:629–39.

    PubMed  CAS  Google Scholar 

  41. Sidransky D, Frost P, Von Eschenbach A, et al. Clonal origin bladder cancer. N Engl J Med 1992; 326:737–40.

    PubMed  CAS  Google Scholar 

  42. Rosin MP, Cairns P, Epstein JI, et al. Partial allelotype of carcinoma in situ of the human bladder. Cancer Res 1995; 55:5213–16.

    PubMed  CAS  Google Scholar 

  43. Mao L, Schoenberg MP, Scicchitano M, et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science 1996; 271:659–62.

    PubMed  CAS  Google Scholar 

  44. Simoneau AR, Jones PA. Bladder cancer: the molecular progression to invasive disease. World J Urol 1994; 12:89–95.

    Article  PubMed  CAS  Google Scholar 

  45. Thiberville L, Payne P, Vielkinds J, et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 1995; 55:5133–9.

    PubMed  CAS  Google Scholar 

  46. Kishimoto Y, Sugio K, Hung JY, et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 1995; 87:1224–9.

    PubMed  CAS  Google Scholar 

  47. Larson AA, Liao S-Y, Stanbridge EJ, et al. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res 1997; 57:4171–6.

    PubMed  CAS  Google Scholar 

  48. Ilyas M, Straub J, Tomlinson IPM, et al. Genetic pathways in colorectal and other cancers. Eur J Cancer 1999; 35:335–51.

    PubMed  CAS  Google Scholar 

  49. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2251–70.

    PubMed  CAS  Google Scholar 

  50. Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem 1992; 16(Suppl G):41–6.

    Google Scholar 

  51. Soloway MS, Perito PE. Superficial bladder cancer: diagnosis, surveillance and treatment. J Cell Biochem 1992; 16(Suppl I):120–7.

    Google Scholar 

  52. Herr HW, Jakse G, Sheinfeld J. The T1 bladder tumor. Semin Urol 1990; 8:254–61.

    PubMed  CAS  Google Scholar 

  53. Harris AL, Neal DE. Bladder cancer—field versus clonal origin. N Engl J Med 1992; 326:759–61.

    PubMed  CAS  Google Scholar 

  54. Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993; 328:901–6.

    PubMed  CAS  Google Scholar 

  55. Burt RW. Cohorts with familial disposition for colon cancers in chemoprevention trials. J Cell Biochem 1996; 25(Suppl):131–5.

    CAS  Google Scholar 

  56. Fabian CJ, Kamel S, Zalles C, et al. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer. J Cell Biochem 1996; 25(Suppl):112–22.

    CAS  Google Scholar 

  57. Westra WH, Sidransky D. Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles. J Natl Cancer Inst 1998; 90:1500–1.

    Article  PubMed  CAS  Google Scholar 

  58. Mao L, El-Naggar AK, Papadimitrakopoulou V, et al. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst 1998; 90:1545–51.

    PubMed  CAS  Google Scholar 

  59. Hittelman WN, Kim HJ, Lee JS. Detection of chromosome instability of tissue fields at risk: in situ hybridization. J Cell Biochem 1996; 25(Suppl):57–62.

    CAS  Google Scholar 

  60. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nature Gen 1999; 21(Suppl):33–7.

    CAS  Google Scholar 

  61. Sneige N, Lagios MD, Schwarting R, et al. Inter-observer reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol 1999; 30:257–62.

    Article  PubMed  CAS  Google Scholar 

  62. Bacus JW, Boone CW, Bacus JV, et al. Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev 1999; 8:1087–94.

    PubMed  CAS  Google Scholar 

  63. Kelloff GJ, Lieberman RL, Steele VE, et al. Chemoprevention of prostate cancer: concepts and strategies. Eur J Urol 1999; 35:342–50.

    CAS  Google Scholar 

  64. Su L-K, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992; 256:668–70.

    PubMed  CAS  Google Scholar 

  65. Jacoby RF, Marshall DJ, Newton MA, et al. Chemoprevention of spontaneous intestinal adenomas in the ApcMin mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 1996; 56:710–14.

    PubMed  CAS  Google Scholar 

  66. Arbeit JM, Howley PM, Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci USA 1996; 93:2930–5.

    Article  PubMed  CAS  Google Scholar 

  67. Boone CW, Stoner GD, Bacus JV, et al. Quantitative grading of rat esophageal carcinogenesis using computer-assisted image tile analysis. Cancer Epidemiol Biomarkers Prev 2000; 9:495–500.

    PubMed  CAS  Google Scholar 

  68. Edelmann W, Yang K, Kuraguchi M, et al. Tumorigenesis in MLH1 and MLH1/Apc1638N mutant mice. Cancer Res 1999; 59:1301–7.

    PubMed  CAS  Google Scholar 

  69. Zhang Z, Liu Q, Lantry LE, et al. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myoinositol and chemotherapeutic agents taxol or adriamycin. Cancer Res 2000; 60:901–7.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Gary J. Kelloff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline C. Sigman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Oncology and Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  2. Division of Cancer Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  3. Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA

    Thomas E. Rohan MB, BS, PhD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Kelloff, G.J., Sigman, C.C. (2002). Chemoprevention. In: Franco, E.L., Rohan, T.E. (eds) Cancer Precursors. Springer, New York, NY. https://doi.org/10.1007/0-387-21605-7_24

Download citation

  • DOI: https://doi.org/10.1007/0-387-21605-7_24

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95188-1

  • Online ISBN: 978-0-387-21605-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation